Oyster Point Pharma Inc.

NASDAQ: OYST · Real-Time Price · USD
11.17
0.00 (0.00%)
At close: Dec 30, 2022, 10:00 PM

Oyster Point Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
24.54M
Cost of Revenue
1.52M
Gross Profit
23.01M
Operating Income
-96.92M
Interest Income
n/a
Pretax Income
-100.66M
Net Income
-104.39M
Selling & General & Admin
95.44M
Research & Development
24.23M
Other Expenses
n/a
Operating Expenses
119.67M
Interest Expense
3.73M
Selling & Marketing Expenses
54.62M
Cost & Expenses
121.19M
Income Tax Expense
3.73M
Shares Outstanding (Basic)
26.04M
Shares Outstanding (Diluted)
26.04M
EPS (Basic)
-4.01
EPS (Diluted)
-4.01
EBITDA
-96.78M
EBIT
-96.92M
Depreciation & Amortization
141K